8/14, 7:17 AM (Source: TeleTrader)
more TeleTrader news


Chart for: Novavax, Inc.

UK to purchase 60M doses of Novavax vaccine

The government of the United Kingdom signed an agreement with American biotechnology company Noavax, Inc. for the purchase of 60 million doses of its coronavirus vaccine candidate.

In a press release published on Friday, Novavax also said the deal covers a phase 3 clinical trial to "assess the efficacy of the vaccine in the UK population." "We are honored to partner with the UK government to deliver a vaccine that could provide vital protection in the fight against the global health crisis," Novavax CEO Stanley C. Erck said.

The vaccine that is being developed by Novavax has shown promising results in an early-stage clinical trial.

Breaking the News / JC